EUVIMEDEUVIMED entdecken
Crossref

Lactate‐Responsive Gene Editing to Synergistically Enhance Macrophage‐Mediated Cancer Immunotherapy

Yuwei Li, Yue Wei, Ying Huang, Geng Qin, Chuanqi Zhao, Jinsong Ren, Xiaogang Qu iD

Small · 2023-08 · 19 (35)

DOI: 10.1002/smll.202301519 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, online erschienen am 08.05.2023. Verfasst von Yuwei Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Chemical Biology and State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy…. Hauptthemen laut MEDLINE: Gene Editing, Neoplasms. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Combination therapies involving metabolic regulation and immune checkpoint blockade are considered an encouraging new strategy for cancer therapy. However, the effective utilization of combination therapies for activating tumor‐associated macrophages (TAMs) remains challenging. Herein, a lactate‐catalyzed chemodynamic approach to activate the therapeutic genome editing of signal‐regulatory protein α (SIRP α ) to reprogram TAMs and improve cancer immunotherapy is proposed. This system is constructed by encapsulating lactate oxidase (LOx) and clustered regularly interspaced short palindromic repeat‐mediated SIRP α genome‐editing plasmids in a metal–organic framework (MOF). The genome‐editing system is released and activated by acidic pyruvate, which is produced by the LOx‐catalyzed oxidation of lactate. The synergy between lactate exhaustion and SIRP α signal blockade can enhance the phagocytic ability of TAMs and promote the repolarization of TAMs to the antitumorigenic M1 phenotype. Lactate exhaustion‐induced CD47‐SIRP α blockade efficiently improves macrophage antitumor immune responses and effectively reverses the immunosuppressive tumor microenvironment to inhibit tumor growth, as demonstrated by in vitro and in vivo studies. This study provides a facile strategy for engineering TAMs in situ by combining CRISPR‐mediated SIRP α knockout with lactate exhaustion for effective immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gene EditingNeoplasmsHumansLactic AcidMacrophagesImmunotherapyTumor Microenvironment

Stichwörter der Autor:innen

cancer immunotherapycrispr/cas9lactatelactate oxidasemetal-organic frameworks (MOFs)

Substanzen

Lactic Acid

Autor:innen und Institutionen

  • Laboratory of Chemical Biology and State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin, 130022, P. R. China.
  • School of Applied Chemistry and Engineering, University of Science and Technology of China, Hefei, Anhui, 230026, P. R. China.

ORCID-Profile: Xiaogang Qu

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Li, Y., Wei, Y., Huang, Y., Qin, G., Zhao, C., Ren, J., & Qu, X. (2023). Lactate‐Responsive Gene Editing to Synergistically Enhance Macrophage‐Mediated Cancer Immunotherapy. Small, 19(35). https://doi.org/10.1002/smll.202301519

Vancouver

Li Y, Wei Y, Huang Y, Qin G, Zhao C, Ren J, et al. Lactate‐Responsive Gene Editing to Synergistically Enhance Macrophage‐Mediated Cancer Immunotherapy. Small. 2023;19(35). doi:10.1002/smll.202301519

BibTeX
@article{Li2023,
  author = {Li, Yuwei and Wei, Yue and Huang, Ying and Qin, Geng and Zhao, Chuanqi and Ren, Jinsong and Qu, Xiaogang},
  title = {Lactate‐Responsive Gene Editing to Synergistically Enhance Macrophage‐Mediated Cancer Immunotherapy},
  journal = {Small},
  year = {2023},
  volume = {19},
  number = {35},
  doi = {10.1002/smll.202301519}
}
Kostenlos starten →